6th International Conference

ON

Pharmaceutics, Formulations & Novel Drug Delivery Systems

Event Date

April 16-17, 2024

Venue

Dubai, UAE

@ Mövenpick Grand Al Bustan Dubai

– QUICK LINKS –

– Previous Conference Performers / Professionals From Around The Globe

Aikaterini Ziaka

Physio4you, Greece

Elizabeth Mahon

Liverpool John Moores University, United Kingdom

Farah naaz Kazi

United Kingdom

Huang Wei Ling, MD,

Brazil

Michael Fossel

Michigan State University , USA

Iskandar r Budianto 

Atma jaya University. Jakarta

Ken Ware

NeuroPhysics Therapy Institute and Research Centre, Australia

Jorge Arturo Hernandez 

Mexico

Nkechi M Enwerem, 

Harvard University,USA

Said El deib

YAS Clinic , UAE

Sandra Velez-Candelario

Family Organizational Psychology LLC, USA

Xu chen

USA

Media Partners/Collaborator

A huge thanks to all our amazing partners. We couldn’t have a conference without you!

Sponsors/Exhibitors

A huge thanks to all our amazing partners. We couldn’t have a conference without you!

PHARMACEUTICS CONFERENCE 2024

Welcome to the 6th International Conference on Pharmaceutics, Formulations & Novel Drug Delivery Systems scheduled for April 16-17, 2024, in Dubai, UAE. This premier Pharma event brings together industry leaders, researchers, and professionals to explore the latest advancements, research, and challenges in pharmaceuticalsciences, clinical research, and related areas.

The conference will be organized around the theme “Advancements of Technologies in Pharmaceutical Sciences”.

In this Hybrid mode, you have the option to join either in-person in Dubai, UAE or virtually from the comfort of your home or workplace.

Highlights of 2024 Conference:

Benefits for Young Scientists:

Conference Highlights

Join us for this exceptional opportunity to explore, learn, and network in the dynamic field of pharmaceuticals. See you in Dubai!

Sessions and Tracks

Track 1: Pharmaceutical Sciences – Academic and Industry Overview

Pharmaceutical Science is a multidisciplinary field that encompasses diverse scientific disciplines such as chemistry, biology, epidemiology, statistics, chemo metrics, mathematics, physics, and chemical engineering. This track provides an extensive overview of the academic and industrial aspects of pharmaceutical sciences, connecting various areas of basic and applied sciences. It explores the intricate processes involved in the design, delivery, action, disposition, and use of drugs.

Track 2: Pharmaceutical Research & Development

This track delves into the dynamic relationship between federal influence and private expenditure in Research & Development (R&D) within the pharmaceutical industry. It scrutinizes programs like healthcare and evaluates the impact of cutting-edge technologies such as Artificial Intelligence, Additive Manufacturing, Blockchain, and other Industry 4.0 advancements on pharmaceutical research and development.

Track 3: Pharmaceutical Chemistry

Pharmaceutical Chemistry is centered on the study, identification, and synthesis of drug metabolic products and related compounds. It involves the intricate processes of designing, developing, and synthesizing pharmaceutical drugs, whether they are derived from natural sources or created synthetically, all for medicinal purposes.

Track 4: Pharmacognosy and Photochemistry

This track explores the intersection of Pharmacognosy and Photochemistry, delving into the study of physical, chemical, and biological properties of drugs from natural sources. It discusses obtaining drugs through computational chemistry, medicinal chemistry, molecular drug design, protein structure prediction, molecular simulation, and exploratory development.

Track 5: Drug Discovery, Design & Development: Challenges and Approaches

Encompassing a broad spectrum of scientific disciplines, this track focuses on the challenges and approaches in drug discovery. It traverses through biology, chemistry, pharmacognosy, medicinal chemistry, and pharmacology, discussing the intricate processes of drug design, development, and the extensive research involved in bringing new pharmaceutical drugs to market.

Track 6: Innovations in Drug Development

This track delves into the ongoing innovations in life sciences, emphasizing the evolving landscape for pharmaceutical companies and pharmacists. It addresses the challenges of adapting and investing for the future while navigating the current market dynamics.

Track 7: Advanced Drug Delivery Systems

Advanced Drug Delivery Systems play a pivotal role in enhancing the efficacy of pharmaceutical compounds, including antibodies, peptides, vaccines, and enzymes. This track emphasizes the advantages of local drug delivery in minimizing side effects and toxicity while maximizing treatment impact.

Track 8: Drug Safety

This track covers the extensive study of drug attainment and culmination in large populations, focusing on risk assessment, risk management, and medication error prevention. It serves as a bridge between clinical pharmacology and epidemiology, ensuring the safety and well-being of patients.

Track 9: Pharmaceutical Analysis

Pharmaceutical Analysis involves the identification, determination, quantification, and purification of chemical components in practical chemistry. It adapts to new regulations and technological advancements, presenting challenges and goals for pharmaceutical formulation.

Track 10: Pharmaceuticals Manufacturing

Delving into the synthesis of pharmaceutical medications, this track breaks down the manufacturing process into unit operations. It covers pharmaceutical packaging, considering factors like protection, compatibility, customer convenience, filling method, sterilization, and cost.

Track 11: Industrial & Physical Pharmacy

Industrial Pharmacy encompasses drug manufacturing, development, marketing, and distribution. Physical Pharmacy, on the other hand, focuses on applying physics and chemistry to pharmaceutical dose form development and in vivo/in vitro activities of pharmaceutical dosage forms.

Track 12: Nano-technology In Pharmaceuticals

Pharmaceutical Nanotechnology applies nanoscience and nanomedicine to pharmacy, playing a key role in overcoming conventional dosage form limitations. It aims to improve bioavailability, patient compliance, and minimize damage to healthy cells.

Track 13: Nanomedicine & Biomedical Applications

This track explores nanotechnology applications in healthcare, emphasizing the use of nanoparticles to enhance drug behavior and delivery. It discusses potential treatments for complex medical challenges in areas like wound healing, tissue regeneration, and mitochondrial diseases.

Track 14: Pharmaceutical Microbiology

Pharmaceutical Microbiology focuses on the use of microorganisms in pharmaceutical production, emphasizing contamination control for drug safety. It plays a crucial role in producing and maintaining microbial-free drug products.

Track 15: Pharmacology & Pharmacovigilance

This track explores the potential of pharmacology in treating and preventing diseases. Additionally, it sheds light on the crucial role of pharmacovigilance in detecting, assessing, understanding, and preventing adverse effects or other drug-related problems, ensuring the safety of pharmaceutical interventions.

Track 16: Radiopharmaceuticals & Biotherapy

This track delves into the use of radiopharmaceuticals for precise imaging in diagnostic purposes and biotherapy, a treatment using substances from living organisms to combat diseases. It explores the evolving landscape of advanced medical interventions.

Track 17: CBD and Cannabinoids

Examining the therapeutic effects of cannabinoids, this track discusses their poorly absorbed nature and high demand for health and wellness purposes, particularly CBD, due to its healing properties. It provides insights into the challenges and opportunities associated with the utilization of cannabinoids in pharmaceutical applications.

Track 18: Formulation Technologies

This track involves the development of stable and patient-acceptable drug formulations. It discusses incorporating drugs into capsules or tablets, ensuring compatibility with other substances, and conducting studies to prevent harm. The focus is on achieving effective and safe drug delivery methods.

Track 19: Contract Formulation Pharmaceutical Ingredients

Covering the development of pharmaceutical ingredients exclusively at the request of specific members or private doctors, this track emphasizes the role of organizations like PCCA in ensuring rights only to the requesting individuals. It sheds light on the tailored approach to pharmaceutical ingredient development.

Track 20: Regulatory Affairs

Highlighting the pivotal role of regulatory affairs in gaining approval for new pharmaceutical products and maintaining approval, this track navigates the complex regulatory landscape in product development and launches. It underscores the significance of compliance with regulatory standards.

Track 21: Preformulation Studies

Preformulation studies focus on the chemical properties of new drug candidates affecting drug performance. These studies provide essential information for formulation design and molecular modification, contributing to the successful development of pharmaceutical products.

Track 22: Clinical Trials

Clinical Trials are designed to safeguard participant health and answer specific research questions. Phases include lab studies, human safety, expanded safety, and efficacy and safety assessments. This track provides insights into the rigorous processes involved in bringing new drugs to market, ensuring their safety and effectiveness.

Market Analysis

The pharmaceutical industry, a cornerstone of global healthcare, is undergoing significant shifts and growth patterns that necessitate a thorough market analysis. One of the primary drivers of this sector is the escalating prevalence of chronic diseases worldwide. As demographics change and lifestyles evolve, the demand for effective treatments rises, stimulating extensive research and development within the industry.

Technological advancements play a pivotal role in shaping the pharmaceutical landscape. The integration of cutting-edge technologies such as Artificial Intelligence (AI), machine learning, and big data analytics expedites drug discovery and development. This not only enhances efficiency but also contributes to more personalized and targeted treatment approaches.

Navigating the complex regulatory landscape is integral to the pharmaceutical market. Stringent regulations and compliance standards, while essential for ensuring patient safety, pose challenges for market entry and product commercialization. Regulatory affairs play a crucial role in obtaining necessary approvals for drug development and marketing.

Globalization is a significant characteristic of the pharmaceutical industry. Companies are increasingly expanding their market presence internationally through strategic partnerships, collaborations, and mergers. While this facilitates access to broader patient populations, it also intensifies competition and requires adaptability to diverse regulatory frameworks.

A notable trend in the industry is the shift towards biopharmaceuticals and specialty medicines. Advances in biotechnology have led to the prominence of biologics, gene therapies, and personalized medicine. These products often target niche markets with high unmet medical needs, providing opportunities for companies to address specific patient populations.

Generic drugs, biosimilars, and a focus on cost-effective healthcare solutions contribute to market dynamics. The expiration of patents for blockbuster drugs has spurred the emergence of generic alternatives, fostering competition and driving down prices. Biosimilars offer more affordable alternatives to complex biologic therapies.

The COVID-19 pandemic has accentuated the industry’s role in global health crises. Rapid vaccine development and deployment underscore the sector’s responsiveness and capability to address urgent healthcare challenges.

In conclusion, the pharmaceutical industry’s market analysis reveals a dynamic landscape influenced by factors such as technological advancements, regulatory complexities, globalization, and a growing focus on biopharmaceuticals. Understanding these trends is essential for stakeholders to make informed decisions in this rapidly evolving and impactful sector.

– Quick Contact –